Dr. Lewiecki is Director of New Mexico Clinical Research & Osteoporosis Center and Director of Bone Health ECHO at University of New Mexico Health Sciences Center in Albuquerque, NM. He is a consultant in osteoporosis and other metabolic bone diseases, supervisor and interpreter of bone density studies, and an educator with a special interest in the evaluation and treatment of osteoporosis and metabolic bone diseases. He has been principal investigator for many osteoporosis clinical trials and is author of over 390 publications in peer-reviewed medical journals with more than 45,000 citations, as well as books, book chapters, and online publications. He is past president of the International Society for Clinical Densitometry (ISCD) and founding president of the Osteoporosis Foundation of New Mexico (OFNM). He is program director of the annual Santa Fe Bone Symposium, the flagship activity of the OFNM. He is Review Editor for Osteoporosis International and is on the editorial board of the Journal of Clinical Densitometry. He has participated with development of ISCD Official Positions (2002, 2004, 2006, 2008, 2011, 2013, 2015, 2019, 2023), International Workshops on the Evaluation and Management of Primary Hyperparathyroidism (2009, 2014, 2022), and osteoporosis treatment guidelines of the National Osteoporosis Foundation / Bone Health & Osteoporosis Foundation (2008, 2014, 2022) and the American Association of Clinical Endocrinologists (2016, 2020), as well as with many other workshops and consensus statements in the field of metabolic bone disease. He has received national and international awards that include the 2021 “Dr. John P. Bilezikian ISCD Global Leadership Award”, and the 2021 “Lawrence G. Raisz Memorial Lecture Award” with the Bone Health & Osteoporosis Foundation, and the 2025 “Santa Fe Bone Symposium Award” in recognition of pioneering contributions to improving skeletal health. He was listed by Expertscape as the #1 osteoporosis expert in the world during the years 2011-2021. ScholarGPS currently lists him as #3 worldwide osteoporosis scholar for the previous 5 years.